Search results
Results from the WOW.Com Content Network
Overview. Multiple endocrine neoplasia, type 2, also called MEN 2, is a rare condition. It causes tumors in the thyroid and parathyroid glands, adrenal glands, lips, mouth, eyes and digestive tract. Genetic testing can find the changed gene that causes MEN 2.
Multiple endocrine neoplasia (MEN) is a rare genetic condition that involves multiple tumors and/or cancer that affect specific endocrine system glands and tissues.
MEN2 is a sub-type of MEN (multiple endocrine neoplasia) and itself has sub-types, as discussed below. Variants in MEN2A have been associated with Hirschsprung disease. Screening for this condition can begin as young as eight years old for Pheochromocytoma.
MEN 2 (Multiple Endocrine Neoplasia Syndrome type 2) is a group of diseases including a type of thyroid cancer called Medullary Thyroid Cancer (MTC). MEN2 is due to a change (mutation) in a gene called RET. This gene mutation can be found with a blood test for genetic testing.
Multiple endocrine neoplasia, type II (MEN II) is a disorder passed down through families in which one or more of the endocrine glands are overactive or form a tumor. Endocrine glands most commonly involved.
Multiple endocrine neoplasia type 2 (MEN2), also known as Sipple syndrome, is a group of rare familial cancer syndromes involving multiple endocrine organs, most commonly thyroid, adrenal glands, and parathyroid.
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant disorder with an estimated prevalence of 1 per 30,000 in the general population. MEN2 is subclassified into two distinct syndromes: types 2A (MEN2A) and 2B (MEN2B).